David Lemus

  • Mr. Lemus has served as director since September 2017
  • He currently serves as a non-executive board member of BioHealth Innovation, Inc., The MIT Club of Washington DC and Proteros BioScience GmbH September 2017
  • From January 2016 to May 2017, he served as Interim CFO and COO of Medigene AG, a publicly-listed German biotechnology company focused on the research and development of T-Cell-Receptor based immunotherapies
  • Prior to that time, at Sigma Tau Pharmaceuticals, Inc., he served as Chief Executive Officer from January 2013 to July 2015, as COO from March 2012 to December 2012, and as V.P. of Finance from July 2011 to February 2012
  • Previous to this, Mr. Lemus served as CFO and Executive V.P. of MorphoSys AG from January 1998 to May 2011
  • Prior to his role at MorphoSys AG, he held various positions, including Operations Manager and Controller (Pharma International Division) and Global IT Project Manager (Pharma Division) at Hoffman La Roche, Group Treasurer of Lindt & Spruengli AG and Treasury Consultant for Electrolux AB Mr
  • B.S., M.S., M.B.A., CPA